IntraClear Biologics is a pioneering bioengineering company focused on addressing the root causes of age-related diseases rather than just their symptoms. Their mission is to control aging through innovative therapies aimed at repairing molecular and cellular damage. The company is developing solutions to remove intracellular waste like lipofuscin and 7-ketocholesterol, which contribute to various age-related conditions. Their current research includes creating a histological atlas of lipofuscin in different tissues. Led by Ariel Feinerman, IntraClear Biologics collaborates with prominent advisors and is dedicated to revolutionising longevity and health.